Literature DB >> 11496090

Glucose alters the susceptibility of mesangial cells to contrast media.

M Wasaki1, J Sugimoto, K Shirota.   

Abstract

RATIONALE AND
OBJECTIVES: Diabetic patients frequently suffer contrast media-induced nephropathy. Hyperglycemia in diabetes mellitus causes gradual deterioration of glomerular mesangial cells (MCs) in the kidney. In this study, the authors investigated the response of rat MCs cultured in high-glucose medium to diatrizoate and iohexol, high- and low-osmolar contrast media, respectively.
METHODS: Isolated rat MCs were precultured under basal-glucose (5.5 mmol/L) and high-glucose (30 and 55 mmol/L) conditions for 24 hours to mimic hyperglycemia in diabetes mellitus and then were exposed to diatrizoate (40 and 80 mg I/mL) and iohexol (80, 120, 160 mg I/mL) for 2 hours. The cytotoxic effects of diatrizoate and iohexol were monitored by neutral red uptake in MCs. The protective effects of an antioxidant, d-alpha-tocopherol (Toc), on cytotoxicity of the contrast media were determined when MCs were precultured with Toc under high-glucose conditions or were exposed to the contrast media together with Toc. Peroxide levels in the cells exposed to the contrast media were analyzed by flow cytometry using dichlorofluorescin diacetate.
RESULTS: Exposure to both contrast media (diatrizoate and iohexol) induced a concentration-dependent decrease in viability of the cells precultured under basal-glucose conditions (5.5 mmol/L). Preculture under high-glucose conditions (30 and 55 mmol/L) augmented the cytotoxic effects of both contrast media. An increase in the intracellular peroxide level was detected after exposure to both contrast media. Preculture with Toc prevented augmentation of the cytotoxic effects of diatrizoate by the higher glucose concentration (55 mmol/L). The exposure to diatrizoate together with Toc also attenuated its cytotoxic effects. Toc showed no such protective effects against iohexol exposure.
CONCLUSIONS: These findings suggest that high-glucose conditions enhance the susceptibility of MCs to the cytotoxic effects of both contrast media; the enhanced susceptibility was in part attributable to oxidative stress caused by high-glucose conditions; diatrizoate exerted the cytotoxic effects by means of oxidative stress; and iohexol appeared to exert its cytotoxicity in a manner different from diatrizoate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11496090     DOI: 10.1097/00004424-200107000-00001

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  5 in total

1.  Iodinated contrast media cause direct tubular cell damage, leading to oxidative stress, low nitric oxide, and impairment of tubuloglomerular feedback.

Authors:  Zhi Zhao Liu; Kristin Schmerbach; Yuan Lu; Andrea Perlewitz; Tatiana Nikitina; Kathleen Cantow; Erdmann Seeliger; Pontus B Persson; Andreas Patzak; Ruisheng Liu; Mauricio M Sendeski
Journal:  Am J Physiol Renal Physiol       Date:  2014-01-15

2.  Probucol Protects Against Contrast-Induced Acute Kidney Injury via the Extracellular Signal-Regulated Kinases 1 and 2 (ERK1/2)/JNK-Caspase 3 Pathway in Diabetic Rats.

Authors:  Xingxing Ma; Zhanquan Jiao; Yanhong Liu; Jun Chen; Guangping Li; Tong Liu; Gary Tse; Ruyu Yuan
Journal:  Med Sci Monit       Date:  2019-02-07

Review 3.  Contrast media viscosity versus osmolality in kidney injury: lessons from animal studies.

Authors:  Erdmann Seeliger; Diana C Lenhard; Pontus B Persson
Journal:  Biomed Res Int       Date:  2014-02-23       Impact factor: 3.411

Review 4.  Molecular mechanisms of renal cellular nephrotoxicity due to radiocontrast media.

Authors:  Ashour Michael; Teresa Faga; Antonio Pisani; Eleonora Riccio; Placido Bramanti; Massimo Sabbatini; Michele Navarra; Michele Andreucci
Journal:  Biomed Res Int       Date:  2014-03-18       Impact factor: 3.411

Review 5.  Radiographic contrast-media-induced acute kidney injury: pathophysiology and prophylactic strategies.

Authors:  Umar Sadat
Journal:  ISRN Radiol       Date:  2013-09-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.